ID   CHB-9
AC   CVCL_A820
SY   CHB09; BCHe003-A
DR   hPSCreg; BCHe003-A
DR   ISCR; 74
DR   NIHhESC; NIHhESC-10-0008
DR   SKIP; SKIP001986
DR   Wikidata; Q54811755
RX   PubMed=18223642;
RX   PubMed=28445466;
CC   From: Children's Hospital Boston; Boston; USA.
CC   Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-10-0008.
CC   Omics: Deep exome analysis.
CC   Omics: SNP array analysis.
CC   Derived from site: In situ; Blastocyst; UBERON=UBERON_0000358.
CC   Cell type: Embryonic stem cell; CL=CL_0002322.
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   Blastocyst stage
CA   Embryonic stem cell
DT   Created: 06-06-12; Last updated: 29-06-23; Version: 14
//
RX   PubMed=18223642; DOI=10.1038/nbt1378;
RA   Lerou P.H., Yabuuchi A., Huo H.-G., Takeuchi A., Shea J., Cimini T.,
RA   Ince T.A., Ginsburg E., Racowsky C., Daley G.Q.;
RT   "Human embryonic stem cell derivation from poor-quality embryos.";
RL   Nat. Biotechnol. 26:212-214(2008).
//
RX   PubMed=28445466; DOI=10.1038/nature22312;
RA   Merkle F.T., Ghosh S., Kamitaki N., Mitchell J., Avior Y., Mello C.,
RA   Kashin S., Mekhoubad S., Ilic D., Charlton M., Saphier G.,
RA   Handsaker R.E., Genovese G., Bar S., Benvenisty N., McCarroll S.A.,
RA   Eggan K.C.;
RT   "Human pluripotent stem cells recurrently acquire and expand dominant
RT   negative P53 mutations.";
RL   Nature 545:229-233(2017).
//